Studien

AREDS 23

Age-Related Eye Disease Study 23

AREDS 24

Age-Related Eye Disease Study 24

AREDS 25

Age-Related Eye Disease Study 25

AREDS 26

Age-Related Eye Disease Study 26

AREDS 27

Age-Related Eye Disease Study 27

AREDS 3

Age-Related Eye Disease Study 3

AREDS 30

Age-Related Eye Disease Study 30

AREDS 36

Age-Related Eye Disease Study 36

AREDS 38

Age-Related Eye Disease Study 38

AREDS 4

Age-Related Eye Disease Study 4

AREDS 5

Age-Related Eye Disease Study 5

AREDS 6

Age-Related Eye Disease Study 6

AREDS 7

Age-Related Eye Disease Study 7

AREDS 8

Age-Related Eye Disease Study 8

AREDS 9

Age-Related Eye Disease Study 9

ARES

Amlodipine REgression Study

ARES

Antiretroviral Regimen Evaluation Study

ARESC

Antimicrobial Resistance Epidemiological Survey on Cystitis

AREST CF

Australian Respiratory Early Surveillance Team for Cystic Fibrosis

AReSVi-006

Efficacy Study of GSK's Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above

ARETA

Analysis of recanalization after endovascular treatment of intracranial aneurysm

AREVA

Anticoagulation et REmplacement VAlvulaire

ARFID

Avoidant Restrictive Food Intake Disorder

ARFY

Atherosclerosis Risk Factors in female Youngsters

ARGAMI

ARGatroban in Acute Myocardial Infarction

ARGAMI-2

ARGatroban in Acute Myocardial Infarction-2

ARGIS-1

Argatroban Anticoagulation in Patients With Acute Ischemic Stroke-1

ARGOS

Safety and Performance Study of the ARGOS-IO (Intraocular) System in Patients With Primary Open Angle Glaucoma (POAG)

ARGOS-02

Safety and Performance Study of the ARGOS-IO (Intraocular) System in Patients With Primary Open Angle Glaucoma (POAG)-02

ARGUS-2

Arterial Hypertension Control in High-Risk Hypertensive Patients

ARI2

Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration

ARIA

A Study to Determine Safety and Efficacy of Dolutegravir/​Abacavir/​Lamivudine (DTG/​ABC/​3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women

ARIA

Amyloid-Related Imaging Abnormalities

ARIA

Appropriateness of Referral and Investigation in Angina trial

ARIA

ARtificially Intelligent image fusion system in comparison to standard treatment to guide endovascular Aortic aneurysm repair

ARIAA

Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk

ARIADNE

A Study of Weight Loss for Diabetes Treatment and Wellbeing

ARIADNE

Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer

ARIAM

Análisis del Retraso en el Infarto Agudo de Miocardio

ARIANNA

Adherence to Mediterranean diet in Italy

ARIC

Atherosclerosis Risk In Community study (1)

ARIC

Atherosclerosis Risk In Community study (2)

ARIC

Atherosclerosis Risk In Community study (3)

ARIC

Atherosclerosis Risk In Community study (4)

ARIC

Atherosclerosis Risk In Community study (5)

ARIC Carotid MRI

Atherosclerosis Risk In Community Carotid MRI study

ARIC community surveillance

Atherosclerosis Risk In Community surveillance

ARIC HS I

Atherosclerosis Risk In Community Hemostasis Study I

ARIC HS II

Atherosclerosis Risk In Community Hemostasis Study II

ARIC-NCS

Atherosclerosis Risk in Communities Neurocognitive Study

ARIC-PET

Atherosclerosis Risk in Communities-Positron Emission Tomography

ARiE

Antibiotics With or Without Rifaximin for Acute Hepatic Encephalopathy in Critically Ill Patients With Cirrhosis

ARIEL

A Study of Rucaparib as Switch Maintenance Following Platinum-Based Chemotherapy in Patients With Platinum-Sensitive, High-Grade Serous or Endometrioid Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer

ARIEL2

A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

ARIEL3

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy

ARIEL4

A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

ARIES

Accessible Resource for Integrated Epigenomic Studies

ARIES

App to support Recovery in Early Intervention Services

ARIES

Avastin(®) Registry - Investigation of Effectiveness and Safety

ARIES

Managing Neovascular (Known as "Wet") Age-related Macular Degeneration Over 2 Years Using Different Treatment Schedules of 2 mg Intravitreal Aflibercept Injected in the Eye (ARIES)